Iodine-123 metaiodobenzylguanidine (123I-MIBG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iodine-123 metaiodobenzylguanidine (123I-MIBG), covering 2011-06-15 to 2011-06-15. Get the full timeline:
Most recent: Clinical Trial Update: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors [Phase 3]